Amedisys(AMED) - 2024 Q2 - Quarterly Results

Exhibit 99.1 AMEDISYS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS BATON ROUGE, Louisiana (July 24, 2024) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 • Net service revenue increased $38.2 million to $591.2 million compared to $553.0 million in 2023. • Net income attributable to Amedisys, Inc. of $32.3 million, which is inclusive of merger-related expenses totaling $11.9 million ...